EyePoint Pharmaceuticals, Inc. — Director's Dealing 2019

Mar 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2019-03-19

Reporting Person: Ross Leonard S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-19	Common Stock	F	1735.00	$2.47	Disposed	74452.00	Direct

Footnotes

F1: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units

F2: Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on March 19, 2019